Exercise and the dipeptidyl-peptidase IV inhibitor sitagliptin do not improve beta-cell function and glucose homeostasis in long-lasting type 1 diabetes-A randomised open-label study.

Seelig, Eleonora; Trinh, Beckey; Hanssen, Henner; Schmid-Trucksäss, Arno; Ellingsgaard, Helga; Christ-Crain, Mirjam; Donath, Marc Y

Seelig, Eleonora; Trinh, Beckey; Hanssen, Henner; Schmid-Trucksäss, Arno; Ellingsgaard, Helga; Christ-Crain, Mirjam; Donath, Marc Y.

Afiliación

Seelig E; Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel Basel Switzerland.
Trinh B; Department of Biomedicine University of Basel Basel Switzerland.
Hanssen H; University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science Addenbrooke's Hospital Cambridge UK.
Schmid-Trucksäss A; Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel Basel Switzerland.
Ellingsgaard H; Department of Biomedicine University of Basel Basel Switzerland.
Christ-Crain M; Department of Sports Medicine, Institute of Exercise and Health Sciences University of Basel Basel Switzerland.
Donath MY; Department of Sports Medicine, Institute of Exercise and Health Sciences University of Basel Basel Switzerland.

Endocrinol Diabetes Metab ; 2(3): e00075, 2019 Jul.

Article en En | MEDLINE | ID: mdl-31294088

Palabras clave

betacell regeneration; dipeptidylpeptidase IV inhibitor; exercise; glucagonlike peptide1; interleukin 6; type 1 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Endocrinol Diabetes Metab Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google